Celcuity Inc. (CELC)
Develops cancer drugs that block cell growth pathways in solid tumors
$82.46+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+106.6%
The outlook
CELC is trading flat today at $82.46, sitting well below both its 50- and 200-day moving averages after a recent pullback. Analysts are notably bullish with a Strong Buy consensus, and their average price target implies roughly 98% upside from current levels. The stock sits in the lower half of its 52-week range, reflecting recent weakness despite the positive analyst outlook.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 11 analysts
Price trendBelow its 50- & 200-day averages
52-week range41% of the way from its 52-week low to high
Price targetAvg target +98% vs current price
Analyst price target
~12-month · 11 analysts$163.54average target+98.3% vs now
Now $82.46
Low $148.00High $178.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$4.02B
52-wk high
$151.02
52-wk low
$34.30
50-day avg
$104.46
200-day avg
$102.99
Trailing P/E
—